Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 4 , Pages 632-638 , April 2008

Evaluation of Platelet Gel Characteristics Using Thrombin Produced by the Thrombin Processing Device: A Comparative Study

  • Elisabeth Semple, PhD

      Affiliations

    • Developmental Scientist, Canadian Blood Services, Research and Development, Toronto, Ontario, Canada.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Semple: St Michael’s Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8 Canada
    • ,
  • Edwin R. Speck, BRT

      Affiliations

    • Senior Research Assistant, Canadian Blood Services, Research and Development, Toronto, Ontario, Canada.
    • ,
  • Rukhsana Aslam, PhD

      Affiliations

    • Research Assistant, Canadian Blood Services, Research and Development, Toronto, Ontario, Canada.
    • ,
  • Michael Kim, BSc

      Affiliations

    • Research Technician, Toronto Platelet Immunobiology Group, St Michael’s Hospital, Toronto, Ontario, Canada.
    • ,
  • Vijay Kumar, PhD

      Affiliations

    • Scientist, Thermogenesis Corp, Rancho Cordova, CA.
    • ,
  • John W. Semple, PhD

      Affiliations

    • Senior Staff Scientist, Department of Laboratory Medicine, St Michael’s Hospital, and Professor of Pharmacology, Departments of Pharmacology, Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

References 

  1. Knighton D, Ciresi K, Fiegel V, et al. Classification and treatment of chronic nonhealing wounds (Successful treatment with autologous platelet-derived wound healing factors (PDWHF)). Ann Surg. 1986;204:322
  2. Steed DL, Goslen JB, Holloway GA, et al. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers (CT-102 activated platelet supernatant, topical versus placebo). Diabetes Care. 1992;15:1598
  3. Stacey MC, Mata SD, Trengove NJ, et al. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg. 2000;20:296
  4. Margolis DJ, Kantor J, Santanna J, et al. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001;24:483
  5. Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: A clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg. 2002;31:281
  6. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;18:27
  7. Senet P, Bon FX, Benbunan M, et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg. 2003;38:1342
  8. Choi BH, Im CJ, Huh JY, et al. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg. 2004;33:56
  9. Giannini G, Mauro V, Agostino T, et al. Use of autologous fibrin-platelet glue and bone fragments in maxillofacial surgery. Transfus Apher Sci. 2004;30:139
  10. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4
  11. Slater M, Patava J, Kingham K, et al. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13:655
  12. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638
  13. Steen VM, Holmsen H. Current aspects on human platelet activation and responses. Eur J Haematol. 1987;38:383
  14. Ledent E, Wasteson A, Berlin G. Growth factor release during preparation and storage of platelet concentrates. Vox Sang. 1995;68:205
  15. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg. 2004;114:1502
  16. Tsay RC, Vo J, Burke A, et al. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg. 2005;63:521
  17. Kajitani M, Ozdemir A, Aguinaga M, et al. Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. J Card Surg. 2000;15:378
  18. Ortel TL, Mercer MC, Thames EH, et al. Immunological impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233:88
  19. Beghi E, Gandolfo C, Ferrarese C, et al. Bovine spongiform encephalopathy and Creutzfeldt-Jacob disease: Fact and uncertainties underlying the causal link between animal and human disease. Neurol Sci. 2004;25:122
  20. Butenas S, Mann KG. Blood coagulation. Biochemistry (Mosc). 2002;67:3
  21. Kumar V, Madsen T, Zhu H, et al. Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device. J Extra Corpor Technol. 2007;39:18
  22. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237
  23. Sayeh E, Sterling K, Speck E, et al. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells. Blood. 2004;103:2705
  24. Nguyen A, Gemmell CH, Yeo EL, et al. Ethanol inhibits thrombin-induced secretion of the contents of human platelet dense and alpha-granules and lysosomes. Thromb Haemost. 1998;80:662
  25. Rubin R. Effect of ethanol on platelet function. Alcohol Clin Exp Res. 1999;23:1114
  26. Bryckaert M, Rendu F, Tobelem G, et al. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Biochem Biophys Res Commun. 1986;135:52
  27. Bryckaert M, Rendu F, Tobelem G, et al. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J Biol Chem. 1989;264:4436
  28. Taylor JJ, Woolsey RM. Dilute ethyl alcohol: Effect on the sciatic nerve of the mouse. Arch Phys Med Rehabil. 1976;57:233
  29. Stephens P, al-Khateeb T, Davies K, et al. An investigation of the interaction between alcohol and fibroblasts in wound healing. Int J Oral Maxillofac Surg. 1996;25:161
  30. Tapani E, Taavitsainen M, Lindros K, et al. Toxicity of ethanol in low concentrations (Experimental evaluation in cell culture). Acta Radiol. 1996;37:923
  31. Luo J, Miller MW. Differential sensitivity of human neuroblastoma cell lines to ethanol: Correlations with their proliferative responses to mitogenic growth factors and expression of growth factor receptors. Alcohol Clin Exp Res. 1997;21:1186
  32. Kim TI, Tchah H, Cho EH, et al. Evaluation for safety of cultured corneal fibroblasts with cotreatment of alcohol and mitomycin C. Invest Ophthalmol Vis Sci. 2004;45:86
  33. De Somer F, De Brauwer V, Vandekerckhove M, et al. Can autologous thrombin with a rest fraction of ethanol be used safely for activation of concentrated autologous platelets applied on nerves?. Eur Spine J. 2006;15:501
  34. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46:155
  35. Bombara C, Ignotz R. TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. J Cell Physiol. 1992;153:30
  36. Semple E, Madsen T, Semple J. Quality of thrombin produced from the patient’s own plasma using the TPDT, a new thrombin processing device. J Extra Corpor Technol. 2005;37:196

PII: S0278-2391(07)01410-3

doi: 10.1016/j.joms.2007.06.623

Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 4 , Pages 632-638 , April 2008

Article Tools

* Image Usage & Resolution